- Home
- PSTV vs FRES Comparison
PSTV vs FRES Comparison
Compare PSTV & FRES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- FRES
- Stock Information
- Founded
- PSTV 1996
- FRES 2010
- Country
- PSTV United States
- FRES United States
- Employees
- PSTV N/A
- FRES N/A
- Industry
- PSTV Medical/Dental Instruments
- FRES Medical Specialities
- Sector
- PSTV Health Care
- FRES Health Care
- Exchange
- PSTV Nasdaq
- FRES Nasdaq
- Market Cap
- PSTV 9.4M
- FRES N/A
- IPO Year
- PSTV N/A
- FRES 2020
- Fundamental
- Price
- PSTV $1.41
- FRES $1.75
- Analyst Decision
- PSTV Strong Buy
- FRES
- Analyst Count
- PSTV 2
- FRES 0
- Target Price
- PSTV $14.00
- FRES N/A
- AVG Volume (30 Days)
- PSTV 84.6K
- FRES 28.5K
- Earning Date
- PSTV 10-29-2024
- FRES 10-29-2024
- Dividend Yield
- PSTV N/A
- FRES N/A
- EPS Growth
- PSTV N/A
- FRES N/A
- EPS
- PSTV N/A
- FRES N/A
- Revenue
- PSTV $5,509,000.00
- FRES $2,341,326.00
- Revenue This Year
- PSTV $11.13
- FRES N/A
- Revenue Next Year
- PSTV N/A
- FRES N/A
- P/E Ratio
- PSTV N/A
- FRES N/A
- Revenue Growth
- PSTV 113.20
- FRES 94.50
- 52 Week Low
- PSTV $0.97
- FRES $1.11
- 52 Week High
- PSTV $2.78
- FRES $18.00
- Technical
- Relative Strength Index (RSI)
- PSTV 46.79
- FRES 51.38
- Support Level
- PSTV $1.20
- FRES $1.63
- Resistance Level
- PSTV $1.45
- FRES $2.36
- Average True Range (ATR)
- PSTV 0.10
- FRES 0.17
- MACD
- PSTV 0.01
- FRES 0.05
- Stochastic Oscillator
- PSTV 57.37
- FRES 33.02
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).